APA (7th ed.) Citation

Değerli, E., Gültürk, İ., Çolak, R., Kapar, C., Durmaz, A. G. S., Canbaz, E. T., . . . Yılmaz, M. (2024). Assessment of Oral Capecitabine in Elderly Patients with Stage 2 Colon Cancer: Toxicity, Tolerability, and Survival Outcomes. Istanbul Medical Journal, 25(4), 336. https://doi.org/10.4274/imj.galenos.2024.64606

Chicago Style (17th ed.) Citation

Değerli, Ezgi, İlkay Gültürk, Rumeysa Çolak, Caner Kapar, Ayşe Gül Satman Durmaz, Esra Turan Canbaz, Mahmut Said Değerli, and Mesut Yılmaz. "Assessment of Oral Capecitabine in Elderly Patients with Stage 2 Colon Cancer: Toxicity, Tolerability, and Survival Outcomes." Istanbul Medical Journal 25, no. 4 (2024): 336. https://doi.org/10.4274/imj.galenos.2024.64606.

MLA (9th ed.) Citation

Değerli, Ezgi, et al. "Assessment of Oral Capecitabine in Elderly Patients with Stage 2 Colon Cancer: Toxicity, Tolerability, and Survival Outcomes." Istanbul Medical Journal, vol. 25, no. 4, 2024, p. 336, https://doi.org/10.4274/imj.galenos.2024.64606.